Evidence map›Paper›PMID 37504722›Full record

ArticleJournal of fungi (Basel, Switzerland)2023

Towards an Early Clinical and Biological Resistance Detection in Dermatophytosis: About 2 Cases of

Giuseppe Russo, Laurence Toutous Trellu, Lionel Fontao, Béatrice Ninet

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Does the use of topical azoles have an impact on antifungal resistance?The Journal of antimicrobial chemotherapy · 2025
    Article
  5. Article
  6. Review
  7. National Belgian Study on Terbinafine Resistance inJournal of fungi (Basel, Switzerland) · 2025
    Article
  8. Dermatophytoses Caused byJournal of fungi (Basel, Switzerland) · 2025
    Article
  9. Expanding the prevalence ofJournal of medical microbiology · 2025
    Review
  10. Cutaneous Infections Caused byJournal of clinical medicine · 2025
    Review
  11. Article
  12. Terbinafine Resistance inJournal of clinical medicine · 2024
    Article
  13. Journal of clinical medicine · 2024
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Giuseppe RussoDivision of Dermatology and Venereology, University Hospital of Geneva, CH-1205 Geneva, Switzerland.
Laurence Toutous TrelluDivision of Dermatology and Venereology, University Hospital of Geneva, CH-1205 Geneva, Switzerland.ORCID 0000-0001-8087-1161
Lionel FontaoDivision of Dermatology and Venereology, University Hospital of Geneva, CH-1205 Geneva, Switzerland.ORCID 0000-0002-5950-564X
Béatrice NinetLaboratory of Dermatology, Division of Laboratory Medicine, University Hospital of Geneva, CH-1205 Geneva, Switzerland.
University Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antifungal susceptibilitydermatophyte infectionterbinafine-resistancetinea corporisTrichophyton indotineae

Identifiers

PMID37504722
PMCPMC10381761
OpenAlexW4383535281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.